BHC Stock Summary and Trading Ideas (Bausch Health Companies | NYSE:BHC)

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health Companies trades on the NYSE stock market under the symbol BHC.

As of April 23, 2024, BHC stock price climbed to $8.53 with 3,917,170 million shares trading.

BHC has a beta of 2.04, meaning it tends to be more sensitive to market movements. BHC has a correlation of 0.15 to the broad based SPY ETF.

BHC has a market cap of $3.12 billion. This is considered a Mid Cap stock.

Last quarter Bausch Health Companies reported $2 billion in Revenue and $1.15 earnings per share. This beat revenue expectation by $108 million and exceeded earnings estimates by $.13.

In the last 3 years, BHC stock traded as high as $34.50 and as low as $4.00.

The top ETF exchange traded funds that BHC belongs to (by Net Assets): ACTV, PPH, DFIS, FDLS, PXF.

BHC has underperformed the market in the last year with a price return of +10.8% while the SPY ETF gained +24.3%. BHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.8% and -12.0%, respectively, while the SPY returned +4.9% and -2.5%, respectively.

BHC support price is $8.13 and resistance is $8.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHC stock will trade within this expected range on the day.